205 related articles for article (PubMed ID: 10980602)
1. A ribonucleotide reductase gene is a transcriptional target of p53 and p73.
Nakano K; Bálint E; Ashcroft M; Vousden KH
Oncogene; 2000 Aug; 19(37):4283-9. PubMed ID: 10980602
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.
Guittet O; Tebbi A; Cottet MH; Vésin F; Lepoivre M
Nitric Oxide; 2008 Sep; 19(2):84-94. PubMed ID: 18474260
[TBL] [Abstract][Full Text] [Related]
3. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
4. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
6. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
[TBL] [Abstract][Full Text] [Related]
7. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
Link PA; Baer MR; James SR; Jones DA; Karpf AR
Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910
[TBL] [Abstract][Full Text] [Related]
8. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
[TBL] [Abstract][Full Text] [Related]
9. Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T; Pützer BM
Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Cancer Lett; 2003 Feb; 190(2):233-43. PubMed ID: 12565178
[TBL] [Abstract][Full Text] [Related]
11. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
12. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
13. Mouse DDA3 gene is a direct transcriptional target of p53 and p73.
Hsieh SC; Lo PK; Wang FF
Oncogene; 2002 May; 21(19):3050-7. PubMed ID: 12082536
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target.
Tullo A; Mastropasqua G; Bourdon JC; Centonze P; Gostissa M; Costanzo A; Levrero M; Del Sal G; Saccone C; Sbisà E
Oncogene; 2003 Nov; 22(54):8738-48. PubMed ID: 14647469
[TBL] [Abstract][Full Text] [Related]
15. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
[TBL] [Abstract][Full Text] [Related]
18. E2F1 regulates p53R2 gene expression in p53-deficient cells.
Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
[TBL] [Abstract][Full Text] [Related]
19. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
[TBL] [Abstract][Full Text] [Related]
20. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
